DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Drilon AE, Sima CS, Somwar R et al.
Phase II study of cabozantinib for patients with advanced RET-rearranged lung cancers.

J Clin Oncol 2015; (suppl): abstr 8007
33

Download Bibliographical Data

Search in: